The FDA Objects to the Sale and Marketing of Nasal, Ophthalmic and Inhalable CBD Products

Canna Law Blog
By Nathalie BougeniesDec 27, 2020, 10:00 am249 pts
On December 22, the Food and Drug Administration (the “FDA”) issued new warning letters to five companies that illegally sold and marketed unapproved CBD products, which the companies claimed could prevent, diagnose, mitigate, treat or cure various medical conditions. This latest round of enforcement…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Legal Pot Delivery 101: A Beginner’s Guide to Cannabis at Your Door 68

Lawmakers urge Trump to act on cannabis 65

Aurora Cannabis denies news of acquisition of New Zealand’s Medleaf Therapeutics 57

Hemp Companies Sue Maryland Over Cannabis Licensing 39

Missouri Hemp Groups Seek to Deregulate Cannabis via Ballot Initiative 38

Delaware Lawmaker Pulls Bill to Restrict Intoxicating Hemp Products 36

Grön, Head Change Debut Exclusive Solventless Edibles in Missouri 35

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.